Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Maintain ADD on Zensar Technologies - Elusive quest for growth - HDFC Securities

Posted On: 2020-05-18 15:34:52


Mr. Apurva Prasad & Mr. Amit Chandra, Institutional Research Analyst, HDFC Securities.

Zensar Technologies (Q4FY20 Results Review) : Elusive quest for growth.

Zensar registered strong margin recovery (+705bps QoQ) but revenue decline was higher than estimate. The deal pipeline continues to be robust (USD 1bn) but TCV has slowed down (-25% YoY) due to Covid-19 related uncertainty. Digital is the key revenue driver but Legacy drag (-9.7% in FY20) is weighing on growth. Delay in decision making, pricing pressure, cut in discretionary spending and high exposure to Hi-Tech, Manufacturing and Retail will pose growth challenges in FY21E. We cut our FY21/22E rev est. by 5.7/5.8% to factor uncertainty. Increase FY21/22E EPS est. by +2.2/+3.9% due to margin reset. Our TP of Rs 98 is based on 8x (~30% discount to 5Y avg.) FY22E EPS. Maintain ADD.

Revenue under pressure: Revenue stood at USD 140.6mn -1.5/-4.2% QoQ/YoY CC lower than exp of USD 142mn led by sharp fall in Legacy (-8.5% QoQ). Decline was led by Covid impact (-450bps), Stress in non-core portfolio offset by reversal of one-time discounts. Growth in 1HFY21E will be impacted due to deferrals of projects and cut in discretionary spending. We assume -6.9/-3.9% fall in rev for 1Q/2Q FY21E with mild recovery in 2H.

Margins improvement: Strong expansion in EBIT margin (9.8% vs 2.8% QoQ) was a positive surprise, but it's down 89bps on YoY basis. The expansion was led by one-time reversals, operating efficiency and better mix. Stringent cost control measures, delay of salary hike, decline in sub-con, hiring freeze and vendor negotiations will support margin in FY21E.

Vertical outlook: Hi-Tech / Manufacturing / Insurance registered decline of 0.7/11.1/3.9 QoQ CC. Retail recovered in the quarter but will remain under stress. Hi-Tech/Manufacturing/Insurance will have challenges. BFS (+6.1% QoQ CC) growth will continue supported by deal wins.

BS highlights: Cash generation improved significantly led by lower DSO days (87 vs 102 days). OCF/EBITDA now stands at healthy 121.5% (3Y average of ~70%). Net Cash stands at Rs 5.75bn which is ~30% of MCap.

Valuation and view. Zensar's organic growth has slipped (+5.8% in FY20 vs. ~9% in FY19) due to high exposure to stressed verticals like Hi-Tech, Manufacturing and Retail. Deal pipeline is healthy at USD 1bn, ~50% of the pipeline are large deals (TCV >USD 10mn), but conversion and growth will remain a challenge in FY21E (-12% YoY). Margin expansion is also difficult considering growth concerns and higher onsite mix. The stock has underperformed in the last 6M (-54%) and currently traded at a P/E of 9.3/7.1x FY21/22E EPS which is at a steep discount to historical average.

Shares of ZENSAR TECHNOLOGIES LTD. was last trading in BSE at Rs.87.3 as compared to the previous close of Rs. 83.15. The total number of shares traded during the day was 52019 in over 323 trades.

The stock hit an intraday high of Rs. 87.3 and intraday low of 85.05. The net turnover during the day was Rs. 4538511.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Maintain BUY on Federal Bank - Challenges more than factored in - HDFC Securities

Maintain BUY on Max Financial - Worst is behind - HDFC Securities

Maintain REDUCE on Dabur - Weak performance, Share gain continues - HDFC Securities

Maintain ADD on Sun Pharma - Specialty scale up delayed - HDFC Securities

Stock Recommendation - Supreme Industries - Accumulate - Geojit

Downgrade to ADD on Aditya Birla Fashion and Retail - Growth gets dearer; Leverage could bite! - HDFC Securities

Maintain ADD on Torrent Pharma - Stable performance, Resilient outlook - HDFC Securities

Analysis on ITC acquiring 100% equity stake in Sunrise Foods Pvt Ltd - HDFC Securities

Maintain ADD on Trent - Savings in Cost of Retailing > GM dilution - HDFC Securities

Maintain SELL on Avenue Supermarts - Un-DMARTesque! - HDFC Securities

Maintain ADD on DCB Bank - Attractive amidst visible headwinds - HDFC Securities

Maintain ADD on Colgate Palmolive - Muted Q4, signs of improving execution - HDFC Securities

Maintain BUY on JMC Projects - Long wait - HDFC Securities

Maintain BUY on JK Lakshmi Cement - Strong margin uptick; Healthy balance sheet - HDFC Securities

Maintain BUY on Kalpataru Power Transmission - Multiple triggers - HDFC Securities

Maintain ADD on BSE - Fighting back, cash support - HDFC Securities

Colgate Palmolive Q4FY20 Result First Cut - Miss on all fronts - HDFC Securities

Maintain ADD on L&T Infotech - Q4FY20 Results Review - HDFC Securities

Maintain Reduce on Dr. Reddy's Labs - Valuations leave little room for disappointment - HDFC Securities

Maintain BUY on UltraTech Cement - Robust margin and leverage performance - HDFC Securities

Maintain BUY on CDSL - Robust performance continues - HDFC Securities

Downgrade to REDUCE on Jubilant FoodWorks - Good franchise, a pause before run - HDFC Securities

ADD on Bajaj Auto - Resilient margins - HDFC Securities

RIL Right's Issue - Mr. Jyoti Roy, DVP Equity Strategist, Angel Broking Ltd

First Cut Analysis: BUY on UltraTech - Healthy results despite Covid impact - HDFC Securities

BUY on Escorts - Strengthening the core - HDFC Securities

Maintain ADD on Crompton Consumer - Q4FY20 Results Review - HDFC Securities

Retain BUY on Nippon Life India Asset Management - Strong core despite market share loss! - HDFC Securities

Maintain ADD on L&T Technology Services - Enduring the ebbs and flows - HDFC Securities

Maintain Buy on Cipla - Positive outlook reaffirmed - HDFC Securities

Maintain BUY on Mahindra & Mahindra Financial Services - Pain inevitable, valuations attractive - HDFC Securities

Maintain SELL on ABB India - Long road to recovery - HDFC Securities

Maintain ADD on Mphasis - Positives outweigh the risks - HDFC Securities

Maintain REDUCE on Siemens - Headwinds remain - HDFC Securities

Maintain ADD on Havells - Recovery Interrupted by Covid - HDFC Securities

ADD on Kotak Mahindra Bank - Stronger than most, but expensive - HDFC Securities

Maintain REDUCE on Godrej Consumers - Weakness continues, exacerbated by Covid - HDFC Securities Institutional Research Desk

First Cut Analysis: Maruti Suzuki India Ltd Q4FY20 Results - HDFC Securities

Vedanta Limited - Voluntary Delisting Proposal - Angel Broking

Shree Cement - Strong show; Valuations remain expensive - Q4FY20 Result Review - HDFC Securities

ICICI Securities - Strong Quarter - Q4FY20 Result Review - HDFC Securities

Cyient - Crash landing - Q4FY20 Result Review - HDFC Securities

ICICI Bank - Well placed for a bumpy ride - Q4FY20 Result Review - HDFC Securities

RBL Bank - Risks to play out - Q4FY20 Result Review - HDFC Securities

Persistent Systems - Growth dichotomy - Q4FY20 Result Review - HDFC Securities

SBI Life Insurance - Challenging Year Ahead - Q4FY20 Result Review - HDFC Securities

Marico - Saffola saves the day - Q4FY20 Result Review - HDFC Securities

AU Small Finance Bank - Better placed vs. peers - Q4FY20 Result Review - HDFC Securities

Reliance Industries - A weak quarter but better visibility on Balance Sheet improvement - Result Review - HDFC Securities

ICICI Lombard - Uncertain times ahead - 4QFY20 Result Review - HDFC Securities







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019